What You Should Know: - Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine. - Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine. Syapse, a San
Francisco, CA-based provider of precision oncology
solutions announced $30
Read More
Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant
AHA Launches COVID-19 Data Challenge to Address Health Disparities Among African Americans, Hispanics, Native Americans in Rural Areas
What You Need to Know: - American Heart Association, Hitachi Vantara and BurstIQ launch COVID-19 Data Challenge to bring global COVID-19 datasets to researchers and clinicians to examine the relationship with other health conditions and health disparities. - Each participant of the challenge will be provided a free, HIPPA compliant and FedRAMP certified, secure Precision Medicine Platform (PMP) workspace to conduct analyses. The American Heart Association, the
Read More
The DNA Company Acquires AI Digital Therapeutics App for $30M to Form My Next Health
What You Should Know: - DNA Company acquires AI-based digital therapeutics app My Pain Sensei (MPS) to form My Next Health and is building a COVID-19 risk assessment platform to help people understand their risks of developing serious COVID-19 complications. - The acquisition combines functional genomics with conversational AI for patient self-management apps and disease tracking tools designed to inform clinician-patient interactions. Leading functional genomics provider The
Read More
Machine Learning Will Transform Medicine, but Only if We Use it Right
World chess champion Garry Kasparov made headlines all over the world in 1997 for something that he probably wasn’t very excited about. He lost a chess match. To a computer. It was an IBM supercomputer called Deep Blue and its victory in that New York City match marked the first time a reigning world chess champion had been defeated by a computer under tournament conditions. It was also a symbolically significant event, the first sign that artificial intelligence could become equal to or even
Read More
COVID-19 Outbreak: The Opportunity & Importance of Health Informatics
Never before has health informatics played a greater role in public health than during the COVID-19 pandemic. While the Health IT industry is certainly challenged due to the overall disruption to the healthcare system, the pandemic undoubtedly underscores the opportunity and importance of health informatics, such as telehealth, remote patient monitoring, patient engagement, AI-based drug discovery, precision medicine, and clinical decision support, but nowhere more pressing than the fields of
Read More
Using Health IT to Preserve Antibiotics and Fight Drug-Resistance
In its latest report on antibiotic resistance, the CDC revealed that infection rates for many threat pathogens are stagnant or in a nominal decline. While this is promising news, there are still a startling 2.8 million cases of drug-resistant infections predicted this year, which will result in an estimated 35,000 deaths. What’s more, the speed at which some patients are developing resistance to last-resort antibiotics – those that are often reserved for special scenarios and designed
Read More
Chilmark Research: The Promise of AI & ML in Healthcare Report
What You Need to Know: - New Chilmark Research report reveals artificial intelligence and machine learning (AI/ML) technologies are capturing the imagination of investors and healthcare organizations—and are poised to expand healthcare frontiers. - The latest report evaluates over 120 commercial AI/ML solutions in healthcare, explores future opportunities, and assesses obstacles to adoption at scale. Interest and investment in healthcare AI/ML tools
is booming with approximately
Read More
TeraRecon Acquired by SymphonyAI: What is the Impact for Medical Imaging Market?
On the 4th March 2020, TeraRecon announced it had signed an agreement to be acquired by the SymphonyAI Group. Here are the facts of the deal, followed by our take on the potential impact on the medical imaging market: - The terms of the deal were not disclosed and TeraRecon will continue to operate business as usual. However, it will benefit from greater financial backing and the synergistic technologies from other companies in the Group’s portfolio. - TeraRecon is an Advanced
Read More
UChicago Medicine Selects Life Image’s Breast Health Data Tool
- UChicago Medicine working with Mammosphere by Life Image to allow patients easy, secure access to their breast imaging and to support the WISDOM Study to establish screening guidelines. - Mammosphere was developed to support women throughout their entire breast health journey, including contributing to scientific research. By offering patients this digital tool, patients in the WISDOM Study will have additional tools to support their long-term commitment to the research.Life Image, the world’s
Read More
Personal Genome Diagnostics, Mayo Clinic Partner to Enhance Patient Care in Oncology
- Together, PGDx and Mayo Clinic will focus on technology optimization and clinical utility studies for liquid biopsy and tissue-based genomic applications.- The shared vision and overall goal for PGDx and Mayo Clinic is to improve patient care by advancing the capabilities of oncology diagnostics testing. Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced a strategic collaboration with Mayo Clinic to enhance the development of clinical diagnostic solutions for
Read More
